CLOSE X
GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
31.39 0.16(0.52%) NAV as on 30 Jul 2025
3.95 % 1 M
9.88 % 1 Y
24.31 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.11

As on 30 Jun, 2025
age-icon Age :

9 yrs 7 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

1,281.99 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.58

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Rajat Srivastava

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jun 30 ,2025
Others 7.68 %
Equity 92.32 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.17 %
Apollo Hospitals Enterprise Ltd.7.19 %
Cipla Ltd.5.76 %
Divi's Laboratories Ltd.5.58 %
Aurobindo Pharma Ltd.5.44 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs58.54
Hospital & Healthcare Services28.53
Business Support2.27
Fertilizers1.17
Insurance0.96
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)14.7317.1815.8825.0628.64
Net Assets(Rs Crores) (as on 31-Mar-2025) 435.03 553.33 493.44 878.70 1183.65
Scheme Returns(%)(Absolute)67.2416.04-7.3157.4613.01
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7541/7567/7619/9020/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.390.16(0.52%)NAV As on 30 Jul, 202528-Dec-2015Inception Date1,281.99AUM In Cr.9.88%1Y24.31%3Y21.03%5Y12.66%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.470.07(0.17%)NAV As on 30 Jul, 202513-Jul-2018Inception Date5,727.59AUM In Cr.17.05%1Y29.50%3Y23.89%5Y22.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity444.965.06(1.15%)NAV As on 30 Jul, 202514-Jul-1999Inception Date3,849.24AUM In Cr.16.99%1Y28.30%3Y23.68%5Y16.41%Since Inception
Nippon India Pharma Fund(G)Very HighEquity536.811.25(0.23%)NAV As on 30 Jul, 202505-Jun-2004Inception Date8,569.15AUM In Cr.10.90%1Y24.95%3Y21.24%5Y20.71%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors